Insiders Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-12-15 EST			5-day change	1st Jan Change
4,481.00 ^JPY	+0.74%		+1.61%	+7.18%

12-07	Takeda, Protagonist Report One-Year Rusfertide Gains in PV trial	MT
12-06	Protagonist Therapeutics, Inc. and Takeda Pharmaceutical Company Limited Present Longer-Term Data At ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera	CI

Insiders

Takeda appoints Rhonda Pacheco president of the U.S. business unit	09-11	RE
Takeda Announces Executive Changes, Effective June 2026	09-11	CI
Takeda Announces Executive Changes, Effective September 29	09-11	CI
Takeda Pharmaceutical Company Limited Announces Change in Compensation Committee Members, Effective June 25, 2025	06-25	CI
Croda International Plc Announces Retirement of Julie Kim from the Board, Effective July 26, 2025	03-03	CI
Takeda Pharmaceutical Names Next CEO	01-30	MT
Takeda Pharmaceutical Company Limited Announces Chief Executive Officer Changes in June 2026	01-30	CI
Takeda Pharmaceutical Company Limited Announces Retirement of Christophe Weber as President and Representative Director in June 2026	01-30	CI
Takeda Pharmaceutical Names U.S. Head Julie Kim as Next CEO -- Update	01-30	DJ
Takeda Pharmaceutical Names Julie Kim Chief Executive	01-30	MT
Japan's Takeda raises full-year forecast after Q3 profit trails forecast	01-30	RE
Takeda CEO Weber on Drug Pipeline, Geopolitical Risks	01-13	MT
Takeda Announces Board and Committee Changes	24-06-26	CI
Takeda Pharmaceutical Company Limited Announces Demise of its Board Member, Olivier Bohuon	24-05-09	CI
Takeda Pharmaceutical Names Milano Furuta as Chief Financial Officer	24-02-01	MT
Antisense Therapeutics Appoints CEO/Managing Director	23-08-06	MT
Takeda Pharmaceutical Company Limited Announces Board Changes	23-06-28	CI
Takeda Pharmaceutical Company Limited Announces Masato Iwasaki, Representative Director Expresses His Intention to Retire on June 28Th	23-03-30	CI
Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO	23-03-29	AN
Takeda Pharmaceutical Company Limited Announces New Assignments of Directors	22-06-29	CI
Takeda Pharmaceutical Company Limited Announces Board Appointments	22-06-29	CI
OncoSec Medical Names Robert Arch CEO; Shares Rise Early	22-04-29	MT
Takeda Pharmaceutical Company Limited Announces Executive Changes	22-04-01	CI
Former Takeda vaccine chief to lead new COVID antiviral venture Aerium	22-03-22	RE
Takeda Announces Management Changes	22-02-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Takeda CEO Weber on Drug Pipeline, Geopolitical Risks

January 13, 2025 at 03:31 pm